Rigetti Computing, Inc. Common Stock
RGTI
$15.36
-7.13%
Rigetti Computing builds quantum computers and superconducting quantum processors, selling systems ranging from 9 to 108 qubits under the Novera and Cepheus brands, and offering cloud access via its Quantum Cloud Services platform. As a pure-play quantum computing company with a market cap of ~$6.1 billion, it is a speculative leader in an emerging industry, competing with IonQ and D-Wave. The current investor narrative centers on the company's cash runway and dilution risk, as highlighted by recent insider stock sales totaling $857 million across the sector, and a $100 million U.S. government grant that validates its technology but does not guarantee near-term revenue. Debate rages over whether the stock is a high-risk hold or a screaming buy given its pre-commercial stage and extreme valuation.…
RGTI
Rigetti Computing, Inc. Common Stock
$15.36
Related headlines
Investment Opinion: Should I buy RGTI Today?
Rating: Hold. Rigetti is a speculative hold at best, given its pre-revenue stage and extreme valuation. The analyst consensus is Buy, but with only three analysts covering, the signal is weak. The average revenue estimate of $223 million implies a forward P/S of ~31x, which is still high but less extreme than the trailing multiple.
Supporting Evidence: The trailing P/S of 968x is unsustainable without massive revenue growth. Revenue declined 17.9% YoY in Q4 2025, and the company has never been profitable. Free cash flow is deeply negative at -$77.2 million TTM. The forward P/S of ~31x based on optimistic revenue estimates of $223 million is still a premium to the sector, but if those estimates are met, the stock could be fairly valued. However, the lack of revenue growth makes those estimates highly uncertain.
Risks & Conditions: This Hold would upgrade to Buy if revenue growth accelerates above 50% YoY and the company demonstrates a credible path to positive free cash flow. It would downgrade to Sell if revenue continues to decline or if the company announces a dilutive offering. The stock is overvalued relative to its history and peers, but the quantum sector is priced for future potential, not current fundamentals.
Sign up to view all
RGTI 12-Month Price Forecast
The AI assessment is bearish with medium confidence. Rigetti's fundamental trajectory is deteriorating, with no revenue growth and deep losses. The valuation is extreme, and insider selling signals a lack of confidence. While government funding provides a floor, the stock is likely to underperform unless there is a dramatic change in revenue growth. The base case of flat revenue and continued dilution is the most probable outcome, leading to a price range of $12-$20. A bullish stance would require evidence of commercialization, which is not yet visible.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rigetti Computing, Inc. Common Stock's 12-month outlook, with a consensus price target around $19.97 and implied upside of +30.0% versus the current price.
Average Target
$19.97
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$12 - $20
Analyst target range
Only 3 analysts cover Rigetti, indicating limited institutional interest typical of small-cap, pre-revenue tech stocks. The consensus recommendation is Buy, with all three analysts (Benchmark, Rosenblatt, Needham) maintaining Buy ratings and Mizuho at Outperform. The average target price is not explicitly provided, but based on the estimated EPS range of -$0.10 to -$0.18 and revenue estimates of $172M–$274M, the implied upside from the current price of $16.54 is difficult to calculate without explicit targets. However, the bullish consensus suggests analysts see significant upside, likely driven by government funding and quantum computing breakthroughs. The target range is wide: the low EPS estimate of -$0.18 implies deeper losses, while the high revenue estimate of $274M implies a forward P/S of ~25x. This wide spread signals high uncertainty about the company's trajectory. The high end assumes rapid government contract wins and commercial adoption, while the low end prices in continued cash burn and dilution. Recent ratings actions are uniformly positive, with B. Riley upgrading from Neutral to Buy in January 2026, and no downgrades. However, the limited coverage means less efficient price discovery, and the stock is prone to sharp moves on news flow.
Bulls vs Bears: RGTI Investment Factors
Rigetti Computing presents a high-risk, high-reward speculative investment. On the bull side, government funding and analyst optimism provide some support, but the bear case is stronger due to stagnant revenue, extreme valuation, and insider selling. The central tension is whether quantum computing will commercialize quickly enough to justify the current market cap of ~$6.1 billion, given that the company generates only ~$7 million in annual revenue. If revenue growth accelerates, the stock could re-rate higher; if not, dilution and cash burn will erode shareholder value.
Bullish
- Government Funding Validates Technology: Rigetti received a $100 million U.S. government grant, which validates its quantum technology and provides non-dilutive capital. This funding supports R&D and extends the cash runway, reducing near-term dilution risk.
- Strong Liquidity Position: The current ratio is 37.4, indicating ample short-term liquidity to cover obligations. With minimal debt (debt-to-equity of 0.013), the balance sheet is not leveraged, providing a cushion against operational losses.
- Analyst Consensus is Bullish: All three covering analysts rate Rigetti a Buy, with no downgrades. The average revenue estimate of $223 million for the next fiscal year implies a forward P/S of ~31x, which is lower than the trailing 968x and suggests potential upside if growth materializes.
- Pure-Play Quantum Exposure: As a pure-play quantum computing company, Rigetti offers direct exposure to a nascent industry with massive long-term potential. The $2 billion federal funding announcement for quantum technology underscores government commitment, which could accelerate commercialization.
Bearish
- Revenue Stagnation and Decline: Q4 2025 revenue was $1.87 million, down 17.9% year-over-year from $2.27 million. Over the past four quarters, revenue has been flat at ~$1.5-1.9 million, showing no growth momentum and undermining the investment thesis.
- Extreme Valuation with No Profits: The trailing P/S ratio is 968x, astronomically high even for a pre-revenue tech stock. The company is deeply unprofitable with a net margin of -9.7% and negative free cash flow of -$19.5 million in Q4 2025, relying on equity financing.
- Insider Selling Red Flag: Insiders at quantum computing companies have sold $857 million in stock over two years with virtually no buying. This signals that those closest to the business are cashing out, raising concerns about the stock's long-term value.
- Cash Burn and Dilution Risk: With negative free cash flow of -$77.2 million over the trailing twelve months and only $47.2 million in common stock issued in Q4 2025, the company will likely need to raise capital again within 12-18 months, diluting existing shareholders.
RGTI Technical Analysis
Rigetti's stock is in a deep downtrend from its 52-week high of $58.15, currently trading at $16.54—just 28.4% of its 52-week range and near the low of $12.08. The 1-year price change of +26.9% masks a severe 33.1% decline over the past 6 months, indicating the stock has given back most of its earlier gains. Trading near the bottom of the range suggests either a value opportunity or a falling knife, depending on one's view of the company's fundamentals. Short-term momentum is bearish: the 1-month price change is -14.9%, while the 3-month change is +12.7%, showing a sharp reversal from a brief rally in May. This divergence—positive 3-month but negative 1-month—signals that the recent uptrend has stalled and may be rolling over, consistent with a failed breakout. The relative strength versus the S&P 500 is -19.0% over 1 month and -41.9% over 6 months, confirming persistent underperformance. The 52-week low of $12.08 provides key support; a break below would signal a new leg lower, targeting the next round number near $10. Resistance sits at the 52-week high of $58.15, but nearer-term resistance is around $20–$22, where the stock stalled in June. With a beta of 1.957, Rigetti is nearly twice as volatile as the market, amplifying both upside and downside moves—critical for position sizing and risk management.
Beta
1.96
1.96x market volatility
Max Drawdown
-77.1%
Largest decline past year
52-Week Range
$12-$58
Price range past year
Annual Return
+26.1%
Cumulative gain past year
| Period | RGTI Return | S&P 500 |
|---|---|---|
| 1m | -26.8% | +1.0% |
| 3m | -9.0% | +7.9% |
| 6m | -40.3% | +8.5% |
| 1y | +26.1% | +20.1% |
| ytd | -34.9% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RGTI Fundamental Analysis
Rigetti's revenue trajectory is stagnant and declining: Q4 2025 revenue was $1.87 million, down 17.9% year-over-year from $2.27 million in Q4 2024. Over the past four quarters, revenue has hovered between $1.47 million and $1.95 million, showing no growth momentum. The company's sole reported revenue segment—access to quantum computing systems—generated only $322,000, highlighting the lack of commercial scale. This stagnation implies that the investment case rests entirely on future potential, not current execution. The company is deeply unprofitable, with a net loss of $18.2 million in Q4 2025 and a net margin of -9.7%. Gross margin was 34.9% in Q4 2025, a sharp improvement from -86.1% in the trailing twelve months, but this is volatile and unsustainable given the low revenue base. Operating margin was -12.1%, and the company has never reported a profitable quarter from operations. The trajectory toward profitability is unclear, as R&D spending of $17.3 million in Q4 2025 far exceeds revenue. Rigetti's balance sheet shows minimal debt (debt-to-equity of 0.013) but negative free cash flow of -$19.5 million in Q4 2025 and -$77.2 million over the trailing twelve months. The company relies on equity financing to fund operations, as evidenced by $47.2 million in common stock issued in Q4 2025. With a current ratio of 37.4, liquidity is ample in the short term, but the cash burn rate suggests the company will need to raise capital again within 12–18 months, diluting existing shareholders. ROE is -39.6%, reflecting severe value destruction.
Quarterly Revenue
$1868000.0B
2025-12
Revenue YoY Growth
-17.8%
YoY Comparison
Gross Margin
34.9%
Latest Quarter
Free Cash Flow
$-77219000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RGTI Overvalued?
Since Rigetti has negative net income and negative EBITDA, the most appropriate valuation metric is the price-to-sales (P/S) ratio. The trailing P/S ratio is 968x, while the forward P/S (based on estimated revenue of $223 million) is roughly 31x—a massive gap that implies the market expects explosive revenue growth. This extreme forward multiple still prices in a highly optimistic scenario. Compared to the industry average (not provided, but typical for hardware/tech), a P/S of 968x is astronomically high, even for a pre-revenue quantum computing company. For context, IonQ trades at a forward P/S of ~50x, making Rigetti's 31x forward appear less extreme but still speculative. The premium reflects the market's bet on quantum commercialization, but the lack of revenue growth undermines this thesis. Historically, Rigetti's P/S ratio has ranged from 14.7x in Q4 2022 to 4,973x in Q3 2025. The current trailing P/S of 968x is near the middle of this range but has compressed from the peak. This suggests that while valuation has moderated from speculative highs, it remains elevated relative to the company's own history, indicating the market still prices in significant future growth. The forward P/S of 31x is near the historical low, implying that if revenue estimates are met, the stock could be reasonably valued—but those estimates are highly uncertain.
PE
-31.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -94x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-32.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Rigetti's financial risks are severe. The company has negative free cash flow of -$77.2 million TTM and a net loss of $18.2 million in Q4 2025, with no clear path to profitability. Revenue is stagnant at ~$1.9 million per quarter, and gross margin is volatile (34.9% in Q4 2025 vs -86.1% TTM). The company relies on equity financing, having issued $47.2 million in stock in Q4 2025, which dilutes existing shareholders. With a cash burn rate that suggests a need for capital within 12-18 months, the risk of further dilution is high.
Market & Competitive Risks: Rigetti trades at a trailing P/S of 968x, far above any reasonable valuation, making it vulnerable to multiple compression. The stock has a beta of 1.957, meaning it is nearly twice as volatile as the market, amplifying downside in sell-offs. Competition from IonQ (which recently swung to profitability) and the upcoming Quantinuum IPO could divert investor attention and capital. The sector is also sensitive to government funding announcements, which can cause sharp but unsustainable rallies.
Worst-Case Scenario: If revenue continues to stagnate and the company fails to secure additional funding, the stock could fall to its 52-week low of $12.08, a -27% decline from the current price of $16.54. In a more extreme scenario, if quantum computing commercialization is delayed further, the stock could retest its historical lows, potentially losing 50% or more. The max drawdown of -77.1% from the 52-week high of $58.15 illustrates the potential downside.
FAQ
The key risks are: 1) Financial risk: The company has negative free cash flow of -$77.2 million TTM and will likely need to raise capital, causing dilution. 2) Valuation risk: The trailing P/S of 968x leaves no room for error; any disappointment could lead to a sharp decline. 3) Competitive risk: IonQ is already profitable, and Quantinuum's IPO could attract capital away from Rigetti. 4) Macro risk: With a beta of 1.957, the stock is highly sensitive to market downturns. The most severe risk is that quantum computing commercialization takes longer than expected, rendering the current valuation unsustainable.
The 12-month forecast is uncertain, with three scenarios: Bull case (20% probability) targets $25-$35, driven by government contracts and revenue growth. Base case (50% probability) targets $12-$20, with flat revenue and continued cash burn. Bear case (30% probability) targets $8-$12, driven by dilution and competitive pressures. The base case is most likely, given the lack of revenue growth and the need for capital. The stock is currently at $16.54, near the lower end of the base case range, suggesting limited upside without a catalyst.
RGTI is overvalued based on traditional metrics. The trailing P/S ratio of 968x is astronomically high, even for a pre-revenue tech stock. The forward P/S of ~31x, based on optimistic revenue estimates of $223 million, is more reasonable but still a premium to the sector. Compared to IonQ, which trades at a forward P/S of ~50x, Rigetti's forward multiple appears lower, but IonQ has demonstrated revenue growth and a path to profitability. The market is pricing in a highly optimistic scenario where Rigetti's revenue grows over 100x from current levels. Given the lack of revenue growth, the stock is overvalued relative to its fundamentals.
RGTI is a high-risk, speculative stock that is not suitable for most investors. The company has stagnant revenue of ~$2 million per quarter, a trailing P/S of 968x, and negative free cash flow of -$77.2 million TTM. While analysts are bullish with a Buy consensus, the limited coverage and extreme valuation make the stock a gamble on quantum computing commercialization. It could be a good buy for those with a high risk tolerance and a long-term horizon, but only as a small position in a diversified portfolio. The biggest downside risk is dilution from future capital raises, which could significantly reduce the value of existing shares.
RGTI is more suitable for long-term, speculative investment, but only for those who can tolerate extreme volatility. The stock has a beta of 1.957 and a max drawdown of -77.1%, making it unsuitable for short-term trading unless one can time the news flow. The company is pre-revenue and may not generate meaningful cash flows for years, so a long-term horizon of 5-10 years is required to see if quantum computing becomes commercial. Short-term traders should be aware of the high risk of sharp declines, as seen in the 33.1% drop over the past 6 months. A minimum holding period of 3-5 years is recommended for those who believe in the technology.